Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 2;7(1):3.
doi: 10.3390/medicines7010003.

Can an Open-Label Placebo Be as Effective as a Deceptive Placebo? Methodological Considerations of a Study Protocol

Leo Druart  1   2 , SaraEve Graham Longsworth  2 , Carole Rolland  2 , Maïa Dolgopoloff  1 , Hugo Terrisse  2 , Jean-Luc Bosson  2 , Nicolas Pinsault  1   2
Affiliations

Can an Open-Label Placebo Be as Effective as a Deceptive Placebo? Methodological Considerations of a Study Protocol

Leo Druart et al. Medicines (Basel). .

Abstract

Background: Placebo has been studied for many years and is ever-present in healthcare. In clinical practice, its use is limited by ethical issues raised by the deception entailed by its administration. Objective: To investigate whether, when given detailed information about pain and underlying placebo mechanisms, subjects will have a response similar to that of those subjected to a procedure in which they receive a conventional placebo treatment. Methods: The study is designed as a non-inferiority randomized, parallel with a nested crossover trial. In addition, 126 subjects without any known pathology will be included. They will be randomized into two groups. Each subject will undergo three Cold Pressor Tests (CPT): calibration, condition of interest (deceptive placebo or educated placebo), and control. Our main judgment criterion will be the comparison in pain intensity experienced on the visual analog scale between the two CPTs with placebo conditions. Results: This study will allow us to rule on the non-inferiority of an "educated" placebo compared to a deceptive placebo in the context of an acute painful stimulation. It is another step towards the understanding of open-label placebo and its use in clinical practice. Conclusions: This study has been approved by the ethics committee in France (2017-A01643-50) and registered on ClinicalTrials.gov (NCT03934138).

Keywords: clinical trial; cold pressor test; ethics; open label placebo; pain; placebo.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
CPT order diagram.
Figure 2
Figure 2
Detailed study flow for a subject. From top to bottom for an animated version of this figure, see: http://bit.ly/Placethic-Figure.
Figure 3
Figure 3
Clinical trial set-up during a CPT test.
See this image and copyright information in PMC

References

    1. Benedetti F., Carlino E., Pollo A. How placebos change the patient’s brain. Neuropsychopharmacology. 2011;36:339–354. doi: 10.1038/npp.2010.81. - DOI - PMC - PubMed
    1. Price D.D., Finniss D.G., Benedetti F. A comprehensive review of the placebo effect: Recent advances and current thought. Annu. Rev. Psychol. 2008;59:565–590. doi: 10.1146/annurev.psych.59.113006.095941. - DOI - PubMed
    1. Ernst E., Resch K.L. Concept of true and perceived placebo effects. BMJ. 1995;311:551–553. doi: 10.1136/bmj.311.7004.551. - DOI - PMC - PubMed
    1. Benedetti F. Placebo and the new physiology of the doctor-patient relationship. Physiol. Rev. 2013;93:1207–1246. doi: 10.1152/physrev.00043.2012. - DOI - PMC - PubMed
    1. Kelley J.M. Lumping and Splitting: Toward a Taxonomy of Placebo and Related Effects. Int. Rev. Neurobiol. 2018;139:29–48. - PubMed

Associated data

Grants and funding

LinkOut - more resources